Professor of Medicine, Massachusetts General Hospital
Endocrinology
Dr. Gilbert H. Daniels, MD
|
|
Give Review
Gilbert Daniels works in the field of Endocrinology. He studied medicine at Harvard Medical School. Harvard Medical School is a top medical university. Harvard Medical School has a rank of 1 in research and a 12 in primary care He received awards:"Paul Starr Award and Lectureship", "America's Top Doctors", "America's Top Doctors for Cancer", "Boston Magazine", "Americas Top Doctors for Cancer", "Whos Who in America", "Top Doctors in Boston", "Nominee for Kranes Award for Excellence in Clinical Teaching", "Charles Burnett Award", "Gilbert H. Daniels Award for Excellence in Teaching", "Distinguished Educator Award", "Distinguished Educator Award of the Endocrine Society", "Boston Herald", "Consumers Guide to Top Doctors", "Best Doctors in America", "Whos Who in the 21st Century Second Edition", "Top doctors for women", "Honored Member", "Nominee : Faculty Award for Excellence in Clinical Teaching", "Distinguished Clinician Award", "Distinguished Clinician: Annual Award", "Best Doctors in America Endocrinology", "The Best Doctors in America, Northeast Region. Endocrinology and Metabolism.", "Best of Boston Endocrinologists", "Outstanding Medical Specialists in the US", "Nominee: Prize for Excellence in Teaching", "Prize of Excellence in Teaching", "Faculty Award", "Alpha Omega Alpha", "Phi Beta Kappa", "Super Doctor", "Most Compassionate Doctor", "Top MD" and "Fellow (FACE)". Gilbert H. Daniels, MD is a published physician. He published 41 publications, including: 'LEADER 2: baseline calcitonin in 9340 people with type 2 diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Resul...' He is registered with Medicare and accepts Medicare payments.
Publications
- Redifferentiation of Iodine-Refractory BRAF V600E-Mutant Metastatic Papillary Thyroid Cancer with Dabrafenib.
- LEADER 2: baseline calcitonin in 9340 people with type 2 Diabetes enrolled in the Liraglutide Effect and Action in Diabetes: Evaluation of cardiovascular outcome Resul...
- Identification of oncogenic mutations and gene fusions in the follicular variant of papillary Thyroid carcinoma.
- Annual financial impact of well-differentiated Thyroid cancer care in the United States.
- How to interpret Thyroid fine-needle aspiration biopsy reports: a guide for the busy radiologist in the era of the bethesda classification system.
- Alemtuzumab-Related Thyroid Dysfunction in a Phase 2 Trial of Patients with Relapsing-Remitting Multiple Sclerosis.
- Imaging behavior of the normal Adrenal on ferumoxytol-enhanced MRI: preliminary findings.
- Pure T3-Thyrotoxicosis from A Mexican Weight Loss Supplement.
- Management of Thyroid nodules with atypical cytology on fine-needle aspiration biopsy.
- BRAF(V600E) status adds incremental value to current risk classification systems in predicting papillary Thyroid carcinoma recurrence.
- Radioactive Iodine: A slice of History.
- Brown fat at PET/CT: correlation with patient characteristics.
- Diagnostic yield of nondiagnostic Thyroid nodules is not altered by timing of repeat biopsy.
- Thyroid lobe ablation with radioactive iodine as an alternative to completion Thyroidectomy after hemiThyroidectomy in patients with follicular Thyroid carcinoma: long...
- Autoimmune Thyroid disease.
- Lobe ablation with radioactive iodine as an alternative to completion Thyroidectomy after hemiThyroidectomy in patients with follicular Thyroid cancer: long-term follo...
- Preoperative basal calcitonin and Tumor stage correlate with postoperative calcitonin normalization in patients undergoing initial surgical management of medullary thy...
- Screening for Medullary Thyroid Carcinoma with Serum Calcitonin Measurements in Patients with Thyroid Nodules in the United States and Canada.
- What if Many Follicular Variant Papillary Thyroid Carcinomas are Not Malignant? A Review of Follicular Variant Papillary Thyroid Carcinoma and a Proposal for a new Cla...
- The American Thyroid Association and American Association of Clinical Endocrinologists' Guidelines for HyperThyroidism and Other Causes of Thyrotoxicosis: An Appraisal.
- The american Thyroid association and american association of clinical endocrinologists guidelines for hyperThyroidism and other causes of thyrotoxicosis: an appraisal.
- Acute Thyrotoxicosis Secondary to Destructive Thyroiditis Associated with Cardiac Catheterization Contrast Dye.
- GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 Diabetes or nondiabeti...
- Hypopituitarism associated with a giant aneurysm of the internal carotid artery.
- A phase II study of gefitinib in patients with advanced Thyroid cancer.
- Article misquote in "Multiple endocrinopathies associated with lithium therapy".
- Sunitinib (sutent)-induced thyrotoxicosis due to destructive Thyroiditis: a case report.
- Prevalence of Thyroid cancer in familial adenomatous polyposis syndrome and the role of screening ultrasound examinations.
- A comparison of short-term changes in health-related quality of life in Thyroid carcinoma patients undergoing diagnostic evaluation with recombinant human thyrotropin ...
- Elevation of Thyroid cancer risk among cutaneous melanoma survivors.
- The thyrotropin reference range should remain unchanged.
- Subclinical Thyroid disease: clinical applications.
- Subclinical Thyroid disease: scientific review and guidelines for diagnosis and management.
- Radioactive iodine lobe ablation as an alternative to completion Thyroidectomy for follicular carcinoma of the Thyroid.
- Evidence-based medicine: common sense discarded.
- Cystic lymph node metastases in papillary Thyroid carcinoma.
- Response to ''Thyrotoxicosis during sunitinib treatment for renal cell carcinoma'' by Grossmann et al.
- Response to ''How do you approach the problem of TSH elevation in a patient on high-dose Thyroid hormone replacement?''.
- Medullary carcinoma.
- Multiple endocrine neoplasia 2A due to a unique C609S RET mutation presents with pheochromocytoma and reduced penetrance of medullary Thyroid carcinoma.
Schools
Harvard Medical School
Massachusetts General Hospital
Uc San Francisco
Conditions Treated
- Abnormal Thyroid
- Acromegaly and Gigantism
- Adrenal Incidentaloma
- Adrenal Insufficiency
- View All
Doctors Specialties
- Endocrinology
Accepted Insurances
- Aetna HMO
- Choice Plus POS II
- American Republic
- Blue Card PPO
- BlueConnect HMO
- Blue with Managed Care Behavioral Health HMO
- Preferred Blue PPO
- CHAMPVA
- Cigna HMO
- Cigna PPO
- Great West Healthcare-Cigna PPO
- Open Access Plus
- Commercial Insurance Company
- Fallon Community Health Plan
- First Health (Coventry Health Care) PPO
- Harvard Pilgrim Health Care PPO
- Medicare Advantage PFFS
- Choice Care PPO
- Mail Handlers Benefit Plan (MHBP)
- Medicare MCR
- MultiPlan PPO
- PHCS Network PPO
- Network Health
- Tufts PPO
- Choice Plus POS
- Navigate HMO
- Navigate POS
- Options PPO
- United Healthcare
Awards
- Paul Starr Award and Lectureship
- America's Top Doctors
- America's Top Doctors for Cancer
- Boston Magazine
- America’s Top Doctors for Cancer
- Who’s Who in America
- Top Doctors in Boston
- Nominee for Krane’s Award for Excellence in Clinical Teaching
- Charles Burnett Award
- Gilbert H. Daniels Award for Excellence in Teaching
- Distinguished Educator Award
- Distinguished Educator Award of the Endocrine Society
- Boston Herald
- Consumers Guide to Top Doctors
- Best Doctors in America
- Who’s Who in the 21st Century – Second Edition
- Top doctors for women
- Honored Member
- Nominee : Faculty Award for Excellence in Clinical Teaching
- Distinguished Clinician Award
- Distinguished Clinician: Annual Award
- Best Doctors in America Endocrinology
- The Best Doctors in America, Northeast Region. Endocrinology and Metabolism.
- Best of Boston Endocrinologists
- Outstanding Medical Specialists in the US
- Nominee: Prize for Excellence in Teaching
- Prize of Excellence in Teaching
- Faculty Award
- Alpha Omega Alpha
- Phi Beta Kappa
- Super Doctor
- Most Compassionate Doctor
- Top MD
- Fellow (FACE)
Education
-
Massachusetts General Hospital -
Harvard Medical School -
Yale College
Hospital
-
Massachusetts General Hospital
Drug Facts
| NPI NUMBER | 1104817311 | |
| NPPES Provider LastName | DANIELS | |
| NPPES Provider FirstName | GILBERT | |
| NPPES Provider ZIPCode | 021143117 | |
| NPPES Provider State | MA | |
| Specialty Description | Endocrinology | |
| Total Claim Count | 985.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1104817311 |
| Last Name Of The Provider | DANIELS |
| First Name Of The Provider | GILBERT |
| View All |
Similar Doctors
|
|
Dr. Geoffrey A. Walford, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Frances J. Hayes, MD
This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Elizabeth C. Bashoff, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Nancy Wei, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Michael Mannstadt, MD
This Doctor is OpenDoctor Recommended.
|
|
Dr. Richard S. Beaser, MD
This Doctor is OpenDoctor Recommended.
|